Please login to the form below

Not currently logged in
Email:
Password:

selonsertib

This page shows the latest selonsertib news and features for those working in and with pharma, biotech and healthcare.

Gilead strikes $5.1bn deal to bolster ties with Galapagos

Gilead strikes $5.1bn deal to bolster ties with Galapagos

Meanwhile, Gilead has had a couple of failed trials with its lead non-alcoholic steatohepatitis (NASH) therapy selonsertib.

Latest news

  • Boehringer bolsters NASH pipeline with $870m Yuhan deal Boehringer bolsters NASH pipeline with $870m Yuhan deal

    Among the big players is Gilead, which recently reported two failed phase 3 trials for ASK1 inhibitor selonsertib and has previously had to abandon two other candidates (simtuzumab and Px-102). ... It’s now hoping for better results from a combination

  • Genfit presses the gas on NASH with combo trials Genfit presses the gas on NASH with combo trials

    moment. It’s notable that Gilead now has a two disappointing late-stage trial readouts for its ASK1 inhibitor selonsertib in NASH, while front-runner Intercept is pitching its candidate Ocaliva

  • Gilead's NASH drug fails again Gilead's NASH drug fails again

    Drug failed to match results from placebo group. Gilead's chances of winning the first-to-market nonalcoholic steatohepatitis (NASH) race has dwindled after one of its key candidates selonsertib failed ... Gilead was hit with very similar news two months

  • Gilead drives NASH development with insitro collaboration Gilead drives NASH development with insitro collaboration

    The move comes not long after the drugmaker released some disappointing late-stage results for its NASH candidate selonsertib, which failed to meet its main goal of improving fibrosis without worsening

  • Novo Nordisk and Gilead join forces in NASH Novo Nordisk and Gilead join forces in NASH

    Gilead has a number of NASH drugs in its pipeline, including a three drug regimen with selonsertib at the core.

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics